Of note, we recently and firstly showed a high and significant correlation between NOS2 and SOX-2 expression in glioma cells [28].Collectively, all of these studies, among others, suggest that NO signaling plays an important role in GSC maintenance and resistance to anticancer therapies. This evidence concerns the gene NOS2 and central nervous system cancer.